<div class="container">

<table style="width: 100%;"><tr>
<td>epi.sssupb</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Sample size for a parallel superiority trial, binary outcome
</h2>

<h3>Description</h3>

<p>Sample size for a parallel superiority trial, binary outcome. 
</p>


<h3>Usage</h3>

<pre><code class="language-R">epi.sssupb(treat, control, delta, n, power, r = 1, nfractional = FALSE, alpha)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>treat</code></td>
<td>
<p>the expected proportion of successes in the treatment group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>control</code></td>
<td>
<p>the expected proportion of successes in the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>delta</code></td>
<td>
<p>the equivalence limit, expressed as the absolute change in the outcome of interest that represents a clinically meaningful difference. For a superiority trial the value entered for <code>delta</code> must be greater than or equal to zero.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n</code></td>
<td>
<p>scalar, the total number of study subjects in the trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>power</code></td>
<td>
<p>scalar, the required study power.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>r</code></td>
<td>
<p>scalar, the number in the treatment group divided by the number in the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nfractional</code></td>
<td>
<p>logical, return fractional sample size.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>
<p>scalar, defining the desired alpha level.</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>A list containing the following: 
</p>
<table>
<tr style="vertical-align: top;">
<td><code>n.total</code></td>
<td>
<p>the total number of study subjects required.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n.treat</code></td>
<td>
<p>the required number of study subject in the treatment group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n.control</code></td>
<td>
<p>the required number of study subject in the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>delta</code></td>
<td>
<p>the equivalence limit, as entered by the user.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>power</code></td>
<td>
<p>the specified or calculated study power.</p>
</td>
</tr>
</table>
<h3>Note</h3>

<p>Consider a clinical trial comparing two groups, a standard treatment (<code class="reqn">s</code>) and a new treatment (<code class="reqn">n</code>). A proportion of subjects in the standard treatment group experience the outcome of interest <code class="reqn">P_{s}</code> and a proportion of subjects in the new treatment group experience the outcome of interest <code class="reqn">P_{n}</code>. We specify the absolute value of the maximum acceptable difference between <code class="reqn">P_{n}</code> and <code class="reqn">P_{s}</code> as <code class="reqn">\delta</code>. For a superiority trial the value entered for <code>delta</code> must be greater than or equal to zero. 
</p>
<p>For a superiority trial the null hypothesis is:
</p>
<p><code class="reqn">H_{0}: P_{s} - P_{n} = 0</code> 
</p>
<p>The alternative hypothesis is:
</p>
<p><code class="reqn">H_{1}: P_{s} - P_{n} != 0</code>
</p>
<p>When calculating the power of a study, the argument <code>n</code> refers to the total study size (that is, the number of subjects in the treatment group plus the number in the control group).
</p>
<p>For a comparison of the key features of superiority, equivalence and non-inferiority trials, refer to the documentation for <code>epi.ssequb</code>.
</p>


<h3>References</h3>

<p>Chow S, Shao J, Wang H (2008). Sample Size Calculations in Clinical Research. Chapman &amp; Hall/CRC Biostatistics Series, page 90.
</p>
<p>Julious SA (2004). Sample sizes for clinical trials with normal data. Statistics in Medicine 23: 1921 - 1986.
</p>
<p>Pocock SJ (1983). Clinical Trials: A Practical Approach. Wiley, New York.
</p>
<p>Wang B, Wang H, Tu X, Feng C (2017). Comparisons of superiority, non-inferiority, and equivalence trials. Shanghai Archives of Psychiatry 29, 385 - 388. DOI: 10.11919/j.issn.1002-0829.217163.
</p>


<h3>Examples</h3>

<pre><code class="language-R">## EXAMPLE 1 (from Chow S, Shao J, Wang H 2008, p. 91):
## Suppose that a pharmaceutical company is interested in conducting a
## clinical trial to compare the efficacy of two antimicrobial agents 
## when administered orally once daily in the treatment of patients 
## with skin infections. In what follows, we consider the situation 
## where the intended trial is for testing superiority of the 
## test drug over the active control drug. For this purpose, the following 
## assumptions are made. First, sample size calculation will be performed 
## for achieving 80% power at the 5% level of significance.

## Assume the true mean cure rates of the treatment agents and the active 
## control are 85% and 65%, respectively. Assume the superiority
## margin is 5%.

epi.sssupb(treat = 0.85, control = 0.65, delta = 0.05, n = NA, 
   power = 0.80, r = 1, nfractional = FALSE, alpha = 0.05)

## A total of 196 subjects need to be enrolled in the trial, 98 in the 
## treatment group and 98 in the control group.

</code></pre>


</div>